FYERS
Home
/
Stocks
/
Profit Loss
/
Rubicon Research Profit & Loss

Rubicon Research Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
₹534 Cr₹514 Cr₹476 Cr₹412 Cr₹352 Cr₹358 Cr₹313 Cr₹296 Cr
₹6 Cr₹3 Cr₹4 Cr₹70 L₹63 L₹10 L₹49 L₹3 Cr
₹540 Cr₹517 Cr₹479 Cr₹413 Cr₹353 Cr₹358 Cr₹314 Cr₹299 Cr
₹420 Cr₹407 Cr₹379 Cr₹330 Cr₹283 Cr₹295 Cr₹253 Cr₹242 Cr
₹135 Cr₹121 Cr₹112 Cr₹95 Cr₹80 Cr₹73 Cr₹70 Cr₹64 Cr
₹9 Cr₹10 Cr₹10 Cr₹11 Cr₹11 Cr₹12 Cr₹8 Cr₹7 Cr
₹110 Cr₹99 Cr₹91 Cr₹72 Cr₹60 Cr₹51 Cr₹53 Cr₹49 Cr
₹85 Cr₹77 Cr₹73 Cr₹54 Cr₹43 Cr₹36 Cr₹38 Cr₹34 Cr

Share Price Live Stats

Open (₹)1,792.00
Volume (₹)3.19 L
High (₹)1,848.60
Upper Circuit2,148.00
Low (₹)1,758.10
Lower Circuit1,432.00
Prev Close1,790.00
52W High (₹)1,899.00
Price1,835.40
52W Low (₹)570.75

Share Market Cap & Key Ratios Overview

M.Cap (₹)29639.30 Cr
Div. Yield (%)0.08
PE Ratio102.84
Debt to Equity0.21
Price to Book10.14
Book Value76.17
EPS (TTM)17.41
Face Value1.00
ROE (%)27.84

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
AUROPHARMANSE
DRREDDYNSE
LUPINNSE
MANKINDNSE
RUBICONNSE
LTP
1W Low
1W High
Market cap (₹)
1840-55 (-2.90%)
1834
1907.80
4,47,236Cr
9322+7 (0.08%)
9119.50
9615
2,49,673Cr
4965.5+51.5 (1.05%)
4823
5000
1,87,460Cr
1119.1-37.8 (-3.27%)
1104.60
1167.70
1,11,521Cr
1366-29 (-2.08%)
1347.70
1398.40
1,11,484Cr
1969+92.3 (4.92%)
1832.70
1981.80
1,04,604Cr
1679.8+19.8 (1.19%)
1646
1704
96,031Cr
1165.5+21.3 (1.86%)
1130
1182
95,220Cr
2095-10 (-0.48%)
2058
2135.50
94,883Cr
2280-38 (-1.64%)
2222
2331.60
92,770Cr
1835.4+87 (4.98%)
1740.50
1870
29,639Cr

Key Highlights of Rubicon Research Ltd’s P&L

In 2026-03-31, Rubicon Research Ltd reported total revenue of ₹1762.66Cr, compared with ₹1296.22Cr in 2025-03-31, reflecting Rubicon Research Ltd turnover.

Depreciation was ₹45.26Cr and finance costs were ₹42.17Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹320.53Cr in 2026-03-31 as compared to ₹194.52Cr in 2025-03-31.

Net Profit (PAT) was ₹246.74Cr in 2026-03-31 compared with ₹134.36Cr in 2025-03-31.

Earnings per share (EPS) were ₹14.95 in 2026-03-31, compared with ₹8.72 in 2025-03-31.